Skip to main content
Toggle navigation
Login
Home
Full Schedule
Home
Full Schedule
All Days
Wed, Aug 2
Thu, Aug 3
Fri, Aug 4
Sat, Sep 30
On Demand
Full Schedule
Type here to filter the list
Wednesday, August 2, 2023
8:00 AM - 8:15 AM
ET
Welcome
8:00 AM - 8:15 AM
ET
Welcome
Co-Chair:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Co-Chair:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
8:15 AM - 8:30 AM
ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant Immunotherapy
8:15 AM - 8:30 AM
ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Neoadjuvant Immunotherapy
Presenter:
Yelena Y. Janjigian, MD
– Memorial Sloan Kettering Cancer Center
8:30 AM - 8:45 AM
ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant Immunotherapy
8:30 AM - 8:45 AM
ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Adjuvant Immunotherapy
Presenter:
Anup Kasi, MD, MPH
– Kansas University Cancer Center
8:45 AM - 9:00 AM
ET
1 - Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers
8:45 AM - 9:00 AM
ET
Session 1: Debate: Neoadjuvant vs Adjuvant Immunotherapy for Locally Advanced HER-2 Positive Upper Gastrointestinal Tract (UGI) Cancers - Discussion
Moderator:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Moderator:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Panelist:
Yelena Y. Janjigian, MD
– Memorial Sloan Kettering Cancer Center
Panelist:
Anup Kasi, MD, MPH
– Kansas University Cancer Center
9:00 AM - 9:15 AM
ET
Break
9:00 AM - 9:15 AM
ET
Break
9:15 AM - 9:30 AM
ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined Immunotherapy
9:15 AM - 9:30 AM
ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Neoadjuvant Combined Immunotherapy
Presenter:
Yelena Y. Janjigian, MD
– Memorial Sloan Kettering Cancer Center
9:30 AM - 9:45 AM
ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Chemotherapy
9:30 AM - 9:45 AM
ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Chemotherapy
Presenter:
Anup Kasi, MD, MPH
– Kansas University Cancer Center
9:45 AM - 10:00 AM
ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC)
9:45 AM - 10:00 AM
ET
Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Discussion
Moderator:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Moderator:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist:
Yelena Y. Janjigian, MD
– Memorial Sloan Kettering Cancer Center
Panelist:
Anup Kasi, MD, MPH
– Kansas University Cancer Center
10:00 AM - 10:15 AM
ET
Break
10:00 AM - 10:15 AM
ET
Break
10:15 AM - 11:15 AM
ET
Non-CME Innvoation Theater
10:15 AM - 11:15 AM
ET
Non-CME Innovation Theater
11:15 AM - 11:30 AM
ET
Break
11:15 AM - 11:30 AM
ET
Break
11:30 AM - 12:15 PM
ET
Session 3: Targeted Agents in Colorectal Cancer: An Update
Presenter:
Heinz-Josef Lenz, MD
– University of Southern California
11:30 AM - 12:15 PM
ET
Session 3: Targeted Agents in Colorectal Cancer: An Update
Presenter:
Heinz-Josef Lenz, MD
– University of Southern California
12:15 PM - 12:30 PM
ET
Break
12:15 PM - 12:30 PM
ET
Break
12:30 PM - 1:15 PM
ET
Session 4: Deciphering Appendiceal Cancer
Presenter:
Deepa Magge, MD, FACS
– Vanderbilt-Ingram Cancer Center
12:30 PM - 1:15 PM
ET
Session 4: Deciphering Appendiceal Cancer
Presenter:
Deepa Magge, MD, FACS
– Vanderbilt-Ingram Cancer Center
1:15 PM - 1:30 PM
ET
Break
1:15 PM - 1:30 PM
ET
Break
1:30 PM - 2:30 PM
ET
Non-CME Innvoation Theater
1:30 PM - 2:30 PM
ET
Non-CME Innovation Theater
2:30 PM - 2:45 PM
ET
Break
2:30 PM - 2:45 PM
ET
Break
2:45 PM - 3:30 PM
ET
Session 5: Clinical Trial Landscape Incorporating ctDNA
Presenter:
Pashtoon M. Kasi, MD, MS
– Weill Cornell Medicine/NewYork-Presbyterian; Englander Institute of Precision Medicine
2:45 PM - 3:30 PM
ET
Session 5: Clinical Trial Landscape Incorporating ctDNA
Presenter:
Pashtoon M. Kasi, MD, MS
– Weill Cornell Medicine/NewYork-Presbyterian; Englander Institute of Precision Medicine
3:30 PM - 3:45 PM
ET
Break
3:30 PM - 3:45 PM
ET
Break
3:45 PM - 4:20 PM
ET
6 - Session 6: Integration of Supportive Care
3:45 PM - 4:20 PM
ET
Session 6: Integration of Supportive Care
Presenter:
Andrew Epstein, MD
– Memorial Sloan Kettering Cancer Center
4:20 PM - 4:30 PM
ET
6 - Live Q&A
4:20 PM - 4:30 PM
ET
Live Q&A
Moderator:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
Moderator:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker:
Andrew Epstein, MD
– Memorial Sloan Kettering Cancer Center
4:30 PM - 4:45 PM
ET
Break
4:30 PM - 4:45 PM
ET
Break
4:45 PM - 5:20 PM
ET
7 - Session 7: Perspectives on Clinical Trial Development in Anal Cancer
4:45 PM - 5:20 PM
ET
Session 7: Perspectives on Clinical Trial Development in Anal Cancer
Presenter:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
5:20 PM - 5:30 PM
ET
7 - Live Q&A
5:20 PM - 5:30 PM
ET
Live Q&A
Moderator:
Jordan D. Berlin, MD
– Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker:
Cathy Eng, MD, FACP, FASCO
– Vanderbilt-Ingram Cancer Center
